di-[2]furyl-hydroxy-acetic acid | 467-58-3

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羟基酸及其衍生物
• 英文名称: di-[2]furyl-hydroxy-acetic acid
• 英文别名: Di-[2]furyl-hydroxy-essigsaeure；2,2-Bis(furan-2-yl)-2-hydroxyacetic acid
• CAS: 467-58-3
• 化学式: C₁₀H₈O₅
• 分子量: 208.171
• InChiKey: BKGYRIITKQLHGT-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.5
• 重原子数：
  15
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.1
• 拓扑面积：
  83.8
• 氢给体数：
  2
• 氢受体数：
  5

反应信息

• 作为产物：
  描述：

  2,2'-联糠醛 在 氢氧化钾 、 sodium hydroxide 、 乙醇 作用下， 生成 di-[2]furyl-hydroxy-acetic acid
  参考文献：
  名称：

  Fischer,E., Justus Liebigs Annalen der Chemie, 1882, vol. 211, p. 218

  摘要：

  DOI：

文献信息

• [EN] 3,6-DISUBSTITUTED AZABICYCLO [3.1.0] HEXANE DERIVATIVES AS MUSCARINIC RECEPTOR ANTAGONISTS<br/>[FR] DERIVES D'AZABICYCLO [3.1.0] HEXANE 3,6-DISUBSTITUES UTILISES COMME ANTAGONISTES DU RECEPTEUR MUSCARINIQUE
  申请人：RANBAXY LAB LTD

  公开号：WO2004052857A1

  公开（公告）日：2004-06-24

  The invention relates to derivatives of 3,6-disubstituted azabicyclo [3.1.0] hexanes of structure (I). The compounds of this invention can function as muscarinic receptor antagonists, and can be used for the treatment of various diseases of the respiratory, urinary and gastrointestinal systems mediated through muscarinic receptors. The invention also relates to pharmaceutical compositions containing the compounds of the present invention and the methods for treating the diseases mediated through muscarinic receptors.

  这项发明涉及结构为(I)的3,6-二取代的氮杂双环[3.1.0]己烷衍生物。本发明的化合物可以作为肌碱受体拮抗剂，可用于治疗通过肌碱受体介导的呼吸系统、泌尿系统和消化系统的各种疾病。该发明还涉及含有本发明化合物的药物组合物以及治疗通过肌碱受体介导的疾病的方法。
• New difurylglycolic acid esters, processes for the preparation thereof as well as the use thereof as pharmaceutical compositions
  申请人：Boehringer Ingelheim Pharma GmbH & Co. KG

  公开号：US20030229227A1

  公开（公告）日：2003-12-11

  Difurylglycolic acid esters of the formula 1 1 wherein X − and the groups A, R, R 1 , R 2 , R 3 and R 3′ may have the meanings given in the claims and in the specification, processes for preparing them and their use for treating asthma, COPD, vagally induced sinus bradycardia, heart rhythm disorders, spasms in the gastrointestinal tract, spasms in the urinary tract or menstrual pain.

  Difurylglycolic acid esters of the formula 11其中X-和A、R、R1、R2、R3和R3'可能具有索赔和说明中给定的含义，用于制备它们的方法以及它们用于治疗哮喘、COPD、迷走神经引起的窦性心动过缓、心律失常、胃肠道痉挛、尿道痉挛或经期疼痛。
• Quinuclidine derivatives and their use as muscarinic M3 receptor ligands
  申请人：——

  公开号：US20030055080A1

  公开（公告）日：2003-03-20

  A compound according to formula (I) 1 wherein: is a phenyl ring, a C 4 to C 9 heteroaromatic compound containing one or more heteroatoms, or a naphthalenyl, 5,6,7,8-tetrahydronaphthalenyl or biphenyl group; R 1 , R 2 and R 3 each independently represent a hydrogen or halogen atom, or a hydroxy group, or a phenyl, —OR 4 , —SR 4 , —NR 4 R 5 , —NHCOR 4 , —CONR 4 R 5 , —CN, —NO 2 , —COOR 4 or —CF 3 group, or a straight or branched lower alkyl group which may optionally be substituted, for example, with a hydroxy or alcoxy group, wherein R 4 and R 5 each independently represent a hydrogen atom, straight or branched lower alkyl group, or together form an alicyclic ring; or R 1 and R 2 together form an aromatic, alicyclic or heterocyclic ring; n is an integer from 0 to 4; A represents a —CH 2 —, —CH═CR 6 , —CR 6 =CH—, —CR 6 R 7 —, —CO—, —O—, —S—, —S(O)—, SO 2 or —NR 6 — group, wherein R 6 and R 7 each independently represent a hydrogen atom, straight or branched lower alkyl group, or R 6 and R 7 together form an alicyclic ring; m is an integer from 0 to 8; provided that when m= 0 , A is not —CH 2 —; p is an integer from 1 to 2 and the substitution in the azoniabicyclic ring may be in the 2, 3 or 4 position including all possible configurations of the asymmetric carbons; B represents a group of formula i) or ii): 2 wherein R 10 represents a hydrogen atom, a hydroxy or methyl group; and R 8 and R 9 each independently represents 3 wherein R 11 represents a hydrogen or halogen atom, or a straight or branched lower alkyl group and Q represents a single bond, —CH 2 —, —CH 2 —CH 2 —, —O—, —O—CH 2 —, —S—, —S—CH 2 — or —CH═CH—, and when i) or ii) contain a chiral centre they may represent either configuration; X represents a pharmaceutically acceptable anion of a mono or polyvalent acid, which shows high affinity for muscarinic M 3 receptors (Hm3).

  根据公式（I）1，其中：是苯环，含有一个或多个杂原子的C4至C9杂芳族化合物，或者是萘基、5,6,7,8-四氢萘基或联苯基；R1、R2和R3分别独立表示氢或卤素原子，或羟基，或苯基，—OR4，—SR4，—NR4R5，—NHCOR4，—CONR4R5，—CN，—NO2，—COOR4或—CF3基团，或直链或支链的较低烷基基团，该基团可以选择性地被取代，例如，取代物可以是羟基或醇基，其中R4和R5分别独立表示氢原子，直链或支链较低烷基基团，或者共同形成脂环；或R1和R2共同形成芳香族、脂环或杂环；n是从0到4的整数；A表示—CH2—，—CH═CR6，—CR6=CH—，—CR6R7—，—CO—，—O—，—S—，—S(O)—，SO2或—NR6—基团，其中R6和R7分别独立表示氢原子，直链或支链较低烷基基团，或R6和R7共同形成脂环；m是从0到8的整数；但是当m=0时，A不是—CH2—；p是从1到2的整数，而在azoniabicyclic环中的取代物可以在2、3或4位置，包括所有可能的手性碳的构型；B表示i)或ii)式的基团，其中R10表示氢原子，羟基或甲基基团；而R8和R9分别表示，其中R11表示氢或卤素原子，或直链或支链较低烷基基团，Q表示单键，—CH2—，—CH2—CH2—，—O—，—O—CH2—，—S—，—S—CH2—或—CH═CH—，当i)或ii)含有手性中心时，它们可以代表任何构型；X表示单价或多价酸的药学上可接受的阴离子，该阴离子对Hm3亲和力高的胆碱能M3受体具有高亲和力。
• Novel quinuclidine derivatives and medicinal compositions containing the same
  申请人：Fernandez Forner Dolors Maria

  公开号：US20060106056A1

  公开（公告）日：2006-05-18

  A compound according to formula (I) wherein: circle around (c)} is a phenyl ring, a C 4 to C 9 heteroaromatic compound containing one or more heteroatoms, or a naphthalenyl, 5,6,7,8-tetrahydronaphthalenyl or biphenyl group; R 1 , R 2 and R 3 each independently represent a hydrogen or halogen atom, or a hydroxy group, or a phenyl, —OR 4 , —SR 4 , —NR 4 R 5 1 —NHCOR 4 , —CONR 4 R 5 , —CN, —NO 2 , —COOR 4 or —CF 3 group, or a straight or branched lower alkyl group which may optionally be substituted, for example, with a hydroxy or alcoxy group, wherein R 4 and R 5 each independently represent a hydrogen atom, straight or branched lower alkyl group, or together form an alicyclic ring; or R 1 and R 2 together form an aromatic, alicyclic or heterocyclic ring; n is an integer from 0 to 4; A represents a —CH 2 —, —CH═CR 6 , —CR 6 ═CH—, —CR 6 R 7 —, —CO—, —O—, —S—, —S(O)—, SO 2 or —NR 6 — group, wherein R 6 and R 7 each independently represent a hydrogen atom, straight or branched lower alkyl group, or R 6 and R 7 together form an alicyclic ring; m is an integer from 0 to 8; provided that when m=0, A is not —CH 2 —; p is an integer from 1 to 2 and the substitution in the azoniabicyclic ring may be in the 2, 3 or 4 position including all possible configurations of the asymmetric carbons; B represents a group of formula i) or ii): wherein R 10 represents a hydrogen atom, a hydroxy or methyl group; and R 8 and R 9 each independently represents wherein R 11 represents a hydrogen or halogen atom, or a straight or branched lower alkyl group and Q represents a single bond, —CH 2 —, —CH 2 —CH 2 —, —O—, —O—CH 2 —, —S—, —S—CH 2 — or —CH—CH—, and when i) or ii) contain a chiral centre they may represent either configuration; X represents a pharmaceutically acceptable anion of a mono or polyvalent acid, which shows high affinity for muscarinic M 3 receptors (Hm 3 ).

  化合物的化学式为（I），其中：圆圈c}是苯环，C4至C9的含有一个或多个杂原子的杂芳环化合物，或萘基，5,6,7,8-四氢萘基或联苯基； R1、R2和R3各自独立地表示氢或卤素原子，或羟基，或苯基，—OR4，—SR4，—NR4R51—NHCOR4，—CONR4R5，—CN，—NO2，—COOR4或—CF3基团，或可选地被取代的直链或支链低烷基，例如，带有羟基或醇基基团，其中R4和R5各自独立地表示氢原子，直链或支链低烷基，或共同形成脂环；或者R1和R2一起形成芳香族，脂环或杂环； n是从0到4的整数； A表示—CH2—，—CH═CR6，—CR6═CH—，—CR6R7—，—CO—，—O—，—S—，—S（O）—，SO2或—NR6—基团，其中R6和R7各自独立地表示氢原子，直链或支链低烷基，或R6和R7一起形成脂环； m是从0到8的整数；当m=0时，A不是—CH2—； p是从1到2的整数，且在氮杂双环中的取代物可以在2、3或4位，包括不对称碳的所有可能构型； B表示以下式子i）或ii）的基团： 其中R10表示氢原子，羟基或甲基基团；R8和R9各自独立地表示 其中R11表示氢或卤素原子，或直链或支链低烷基，Q表示单键，—CH2—，—CH2—CH2—，—O—，—O—CH2—，—S—，—S—CH2—或—CH—CH—，当i）或ii）包含手性中心时，它们可以表示任何构型； X表示具有高亲和力的药学可接受的单价或多价酸的阴离子，对肌动蛋白M3受体（Hm3）显示高亲和力。
• NOVEL QUINUCLIDINE DERIVATIVES AND MEDICINAL COMPOSITIONS CONTAINING THE SAME
  申请人：Fernandez Forner Maria Dolors

  公开号：US20100234333A1

  公开（公告）日：2010-09-16

  A compound according to formula (I) wherein: circle around (C)} is a phenyl ring, a C 4 to C 9 heteroaromatic compound containing one or more heteroatoms, or a naphthalenyl, 5,6,7,8-tetrahydronaphthalenyl or biphenyl group; R 1 , R 2 and R 3 each independently represent a hydrogen or halogen atom, or a hydroxy group, or a phenyl, —OR 4 , —SR 4 , —NR 4 R 5 , —NHCOR 4 , —CONR 4 R 5 , —CN, —NO 2 , —COOR 4 or —CF 3 group, or a straight or branched lower alkyl group which may optionally be substituted, for example, with a hydroxy or alcoxy group, wherein R 4 and R 5 each independently represent a hydrogen atom, straight or branched lower alkyl group, or together form an alicyclic ring; or R 1 and R 2 together form an aromatic, alicyclic or heterocyclic ring; n is an integer from 0 to 4; A represents a —CH 2 —, —CH═CR 6 , —CR 6 ═CH—, —CR 6 R 7 —, —CO—, —O—, —S—, —S(O)—, SO 2 or —NR 6 — group, wherein R 6 and R 7 each independently represent a hydrogen atom, straight or branched lower alkyl group, or R 6 and R 7 together form an alicyclic ring; m is an integer from 0 to 8; provided that when m=0, A is not —CH 2 —; p is an integer from 1 to 2 and the substitution in the azoniabicyclic ring may be in the 2, 3 or 4 position including all possible configurations of the asymmetric carbons; B represents a group of formula i) or ii): wherein R 10 represents a hydrogen atom, a hydroxy or methyl group; and R 8 and R 9 each independently represents wherein R 11 represents a hydrogen or halogen atom, or a straight or branched lower alkyl group and Q represents a single bond, —CH 2 —, —CH 2 —CH 2 —, —O—, —O—CH 2 —, —S—, —S—CH 2 — or —CH═CH—, and when i) or ii) contain a chiral centre they may represent either configuration; X represents a pharmaceutically acceptable anion of a mono or polyvalent acid, which shows high affinity for muscarinic M 3 receptors (Hm3).

  化合物的化学式为（I），其中： 圆圈C}是苯环，含有一个或多个杂原子的C4到C9杂环化合物，或萘基，5,6,7,8-四氢萘基或联苯基； R1、R2和R3分别独立地表示氢或卤素原子，或羟基，或苯基，—OR4，—SR4，—NR4R5，—NHCOR4，—CONR4R5，—CN，—NO2，—COOR4或—CF3基团，或直链或支链的低碳烷基，可以选择性地被取代，例如，羟基或醇基基团，其中R4和R5分别独立地表示氢原子，直链或支链低碳烷基，或一起形成脂环；或R1和R2一起形成芳香族，脂环或杂环； n是从0到4的整数； A表示—CH2—，—CH═CR6，—CR6═CH—，—CR6R7—，—CO—，—O—，—S—，—S（O）—，SO2或—NR6—基团，其中R6和R7分别独立地表示氢原子，直链或支链低碳烷基，或R6和R7一起形成脂环； m是从0到8的整数；但当m=0时，A不是—CH2—； p是从1到2的整数，且在氮杂双环环中的取代可以在2,3或4位置，包括不对称碳的所有可能构型； B表示式i）或ii）的基团： 其中R10表示氢原子，羟基或甲基基团；R8和R9各自独立地表示 其中R11表示氢或卤素原子，或直链或支链低碳烷基，而Q表示单键，—CH2—，—CH2—CH2—，—O—，—O—CH2—，—S—，—S—CH2—或—CH═CH—，当i）或ii）包含手性中心时，它们可以表示任何构型； X表示单价或多价酸的药物可接受的阴离子，具有高亲和力的毒蕈碱M3受体（Hm3）。